MyChesCo on MSN21h
Palvella Therapeutics Begins Phase 3 Trial for Microcystic Lymphatic Malformations TreatmentPalvella Therapeutics, Inc. has announced the commencement of dosing in its Phase 3 SELVA trial, aimed at evaluating QTORIN™ ...
Studies have shown that Plan B and other oral contraceptives with levonorgestrel can be less effective in people who are ...
The unlisted ingredients can cause "life threatening" drops in blood pressure when used in combination with other prescription drugs.
Laser Photonics Corporation has acquired Control Micro Systems to expand its market reach into the pharmaceutical industry ... and capitalize on growing demand for laser-based drug delivery and ...
Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...
AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...
When patents for name brand medicines expire, the price of that medicine drops significantly as generic versions enter the market, but that process can take a while.
European Union antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings’ acquisition of contract drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback